Corsicana & Co. »

Atrium Therapeutics shares owned by Corsicana & Co.

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Corsicana & Co. from 13F filings

Historical chart of Corsicana & Co. investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Corsicana & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Corsicana & Co.

Quarter filed Position value Share count Share price at filing
2026-06-30 $132k 9.8k 13.45

More positions owned by Corsicana & Co.

iShares Russell 2000 ETF Russell 2000 Etf (IWM)
State Street SPDR S&P Mid-Cap 400 ETF Trust Utser1 S&pdcrp (MDY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
SPDR S&P Dividend ETF State Street Spd (SDY)
State Street Technology Select Sector SPDR ETF State Street Tec (XLK)
State Street SPDR S&P 500 ETF Trust Tr Unit (SPY)
Microsoft Corporation (MSFT)
iShares Morningstar Growth ETF Morningstar Grwt (ILCG)
iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Texas Instruments Incorporated (TXN)
Udr (UDR)
Johnson & Johnson (JNJ)
Exxon Mobil Corporation (XOM)
iShares Core MSCI EAFE ETF Core Msci Eafe (IEFA)

View all positions for Corsicana & Co.

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation

View all funds holding Atrium Therapeutics